Published in J R Soc Interface on August 28, 2013
Building our youth for the future. J Int AIDS Soc (2015) 1.13
Health benefits, costs, and cost-effectiveness of earlier eligibility for adult antiretroviral therapy and expanded treatment coverage: a combined analysis of 12 mathematical models. Lancet Glob Health (2013) 0.87
Development, calibration and performance of an HIV transmission model incorporating natural history and behavioral patterns: application in South Africa. PLoS One (2014) 0.80
Tuberculosis in Cape Town: An age-structured transmission model. Epidemics (2015) 0.79
Age-targeted HIV treatment and primary prevention as a 'ring fence' to efficiently interrupt the age patterns of transmission in generalized epidemic settings in South Africa. Int Health (2016) 0.78
Targeting HIV services to male migrant workers in southern Africa would not reverse generalized HIV epidemics in their home communities: a mathematical modeling analysis. Int Health (2015) 0.78
Sexual partnership age-pairings and risk of HIV acquisition in rural South Africa: a population-based cohort study. AIDS (2017) 0.76
Age differences between sexual partners, behavioural and demographic correlates, and HIV infection on Likoma Island, Malawi. Sci Rep (2016) 0.75
Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med (2011) 69.36
Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group. N Engl J Med (2000) 41.18
Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. N Engl J Med (2012) 27.84
Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana. N Engl J Med (2012) 20.03
Heterosexual HIV-1 transmission after initiation of antiretroviral therapy: a prospective cohort analysis. Lancet (2010) 16.90
Sexual transmission of HIV according to viral load and antiretroviral therapy: systematic review and meta-analysis. AIDS (2009) 11.62
HIV treatment as prevention: systematic comparison of mathematical models of the potential impact of antiretroviral therapy on HIV incidence in South Africa. PLoS Med (2012) 4.08
The impact of the new WHO antiretroviral treatment guidelines on HIV epidemic dynamics and cost in South Africa. PLoS One (2011) 1.67
Survival of HIV-infected treatment-naive individuals with documented dates of seroconversion in Rakai, Uganda. AIDS (2007) 1.63
Transitioning HIV care and treatment programs in southern Africa to full local management. AIDS (2012) 1.47
Ageing with HIV in South Africa. AIDS (2011) 1.37
Age as a determinant of survival in HIV infection. J Clin Epidemiol (2001) 1.14
Fitting the HIV epidemic in Zambia: a two-sex micro-simulation model. PLoS One (2009) 1.08
Polygyny and symmetric concurrency: comparing long-duration sexually transmitted infection prevalence using simulated sexual networks. Sex Transm Infect (2010) 0.89
HIV treatment as prevention: systematic comparison of mathematical models of the potential impact of antiretroviral therapy on HIV incidence in South Africa. PLoS Med (2012) 4.08
Riboswitches: small-molecule recognition by gene regulatory RNAs. Curr Opin Struct Biol (2007) 2.11
Most plastic products release estrogenic chemicals: a potential health problem that can be solved. Environ Health Perspect (2011) 1.63
Predictive spatial risk model of poliovirus to aid prioritization and hasten eradication in Nigeria. BMC Med (2014) 1.35
A mathematical model of the impact of present and future malaria vaccines. Malar J (2013) 1.23
The glmS ribozyme tunes the catalytically critical pK(a) of its coenzyme glucosamine-6-phosphate. J Am Chem Soc (2011) 1.04
Dropout and re-enrollment: implications for epidemiological projections of treatment programs. AIDS (2014) 0.92
Calibration of an intrahost malaria model and parameter ensemble evaluation of a pre-erythrocytic vaccine. Malar J (2015) 0.91
Detecting progression of nuclear sclerosis by using human grading versus semiautomated computer grading. Invest Ophthalmol Vis Sci (2005) 0.81
Structure of the bacterial deacetylase LpxC bound to the nucleotide reaction product reveals mechanisms of oxyanion stabilization and proton transfer. J Biol Chem (2013) 0.80
PharmGKB summary: gemcitabine pathway. Pharmacogenet Genomics (2014) 0.78
A model of HIV drug resistance driven by heterogeneities in host immunity and adherence patterns. BMC Syst Biol (2013) 0.77
Identification and in Vivo Evaluation of Liver X Receptor β-Selective Agonists for the Potential Treatment of Alzheimer's Disease. J Med Chem (2016) 0.75
Influence of high-order nonlinear fluctuations in the multivariate susceptible-infectious-recovered master equation. Phys Rev E Stat Nonlin Soft Matter Phys (2012) 0.75